Ohio State University: Diabetes Mellitus trials
The registry lists 16 Diabetes Mellitus studies with Ohio State University as lead sponsor. 4 are open to participants now and 3 have results posted.
Phase 1 1Phase 4 3No phase 12(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor AgonistsRecruitingNCT07702461
- Group Emotion-Focused Behavioral Intervention for Diabetes Distress/A1c in T2D.Not yet recruitingNCT06912737Not applicable
- Occupational Therapy and Registered Dietitian Services to Reduce Fall Risk Among Home Delivered Meal ClientsRecruitingNCT06586970Not applicable
- DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational DiabetesRecruitingNCT06445946Phase 4
- Effectiveness of a Diabetes Focused Discharge Order Set Among Poorly Controlled Hospitalized Patients Transitioning to Glargine U300 InsulinTerminatedNCT03455985Not applicableResults posted
- A Family-Based Diabetes Intervention for Hispanic Adults in an Emerging CommunityCompletedNCT02114814Not applicableResults posted
- Transitioning Open Heart Surgery Patients From Insulin Infusions to DetemirCompletedNCT00717288Phase 4Results posted
- Continuous Glucose Monitoring (CGM) Substudy of the DECIDE RCTWithdrawnNCT06490874
- Continuous Glucose Monitoring for Women With Diabetes Mellitus in the Intrapartum and Postpartum Inpatient CareStatus unknownNCT05492890
- Continuous Glucose Monitoring for Personal Protective Equipment EvaluationStatus unknownNCT05478070Not applicable
- Empagliflozin in Adolescent DiabetesWithdrawnNCT04917692Phase 4
- Cooking Matters for Diabetes - A 6-Week Program for Practical Application of Diabetes Self-Management EducationCompletedNCT04152811Not applicable
- Integrated Second Language Learning for Chronic CareCompletedNCT02864160Not applicable
- Effects of Capros in Patients With Type-1 DiabetesCompletedNCT02634216Not applicable
- Islet Allotransplantation in Type 1 DiabetesSuspendedNCT01705899Phase 1
- Supplementation With Conjugated Linoleic Acid (CLA) as Complementary Therapy in the Management of Type 2 Diabetes Mellitus (Women's Diabetes Study)CompletedNCT01121471Not applicable